| Press Release - | Sterilization Equipment Market to Reach 39.57 Billion by 2034 |
Vantage Market Research | 06 Nov 2024
Healthcare
Sterilization Equipment Market to Reach 39.57 Billion by 2034

Vantage Market Research releases its latest comprehensive report on the ‘Sterilization Equipment Market’ with a forecast period of 2025-2034. In 2023, the global sterilization equipment market size was USD 14.73 billion, and is calculated at USD 16.11 billion in 2024. The market is projected to reach USD 39.57 billion in 2034, and register a revenue CAGR of 9.4% over the forecast period (2025-2034).
Global sterilization equipment market revenue growth continues to incline steadily due to factors such as rising demand for sterilization equipment in healthcare settings and facilities to ensure patient safety and security, meet compliances and requisites, maintain safety and hygiene standards of products, components, devices, tests, and samples, among others. Also, increasingly stringent hygiene and quality standards in healthcare, pharmaceuticals, and food industries are driving demand for various equipment in these industries.
Rising prevalence of chronic and infectious diseases, increasing number of surgical procedures, risks of Hospital-Acquired Infections (HAIs), Urinary Tract Infections (UTI), and surgical site infections, among others, and regulatory mandates on sterilization practices are other key factors driving growth of the sterilization equipment market.
Technological advancements, such as emergence and use of plasma and ozone sterilization, offering faster, more eco-friendly solutions, are supporting further demand. Also, the growing trend toward portable and automated systems supports decentralized healthcare and point-of-care applications. In addition, sustainability concerns and innovations in material science are driving the adoption of energy-efficient, high-performance sterilization technologies, and this is also contributing to global market growth.
Various types of equipment and technologies are widely used in healthcare, pharmaceuticals, food processing, and biotechnology to sterilize medical devices, surgical instruments, lab equipment, and consumables. Common sterilization products include heat sterilizers comprising depyrogenation ovens and steam autoclaves; low-temperature sterilizers such as ethylene oxide sterilizers, hydrogen peroxide sterilizers, and others; sterile membrane filters, radiation sterilization devices that use electron beams and gamma rays; nitrogen dioxide sterilizers, and others.
Manufacturers are focusing on enhancing safety and effectiveness of systems by incorporating advanced control systems, automation, and real-time monitoring. This ensures consistent performance and minimizes risks associated with sterilization errors. One of the key trends in the market is the growing demand for compact, portable sterilization equipment, especially in point-of-care and decentralized healthcare settings. Also, sustainability is a priority driving the adoption of eco-friendly technologies that reduce energy consumption and waste.
Advancements in material science are allowing for development of sterilization equipment and devices that are durable, easy to clean, and resistant to harsh sterilization conditions. The need to comply with increasingly more stringent hygiene practices across industries is expected to continue to drive demand for and adoption of sterilization equipment, and also encourage development of more innovative, cost-effective, and safe sterilization solutions.
June 3, 2024: Getinge unveiled the Poladus 150, which is its latest innovation in low-temperature sterilization, designed for heat-sensitive surgical instruments. Equipped with advanced cross-contamination barrier technology, Poladus 150 plays a crucial role in preventing healthcare acquired infections. This development marks entry via the company’s Infection Control business to be a leading player in the field of VH2O2 low-temperature sterilization. The sterilizer’s innovative Cross-Contamination Barrier (CCB) design ensures separate air flows in different zones, preventing the spread of harmful bacteria and viruses. This reduces the risk of cross-contamination and helps prevent HCAI, which pose a significant risk to patients and can result in severe complications and prolonged hospital stays.
January 8, 2024: The U.S. Food and Drug Administration (FDA) announcing that Vaporized Hydrogen Peroxide (VHP) is an established method of sterilization for medical devices, after recognizing long history of safety and effectiveness of VHP. This move will facilitate broader adoption of VHP as a sterilization method for the medical device industry, and aligns with FDA’s multi-pronged approach to reducing the use of ethylene oxide (EtO) where possible, as well as supports efforts to advance medical device supply chain resiliency.
By Product:
By End-User:
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
About Vantage Market Research:
We, at Vantage Market Research, provide quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies. The company provides high quality data and market research services. The company serves various enterprises and clients in a wide variety of industries. The company offers detailed reports on multiple industries including Chemical Materials and Energy, Food and Beverages, Healthcare Technology, etc. The company’s experienced team of Analysts, Researchers, and Consultants use proprietary data sources and numerous statistical tools and techniques to gather and analyse information.
Healthcare
Sterilization Equipment Market to Reach 39.57 Billion by 2034
06 Nov 2024
Min Read
Access Full Report
Sterilization Equipment Market to Reach 39.57 Billion by 2034
This report by Vantage Market Research delivers comprehensive analysis of Somatostatin Analogs Market , focusing on Market Size, Share & Trends Analysis Report by Type (Octreotide, Lanreotide, Pasireotide) by Application (Acromegaly, Neuroendocrine Tumors (NETs), Others) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)
Request SampleRelated Reports
Latest Press Release
Contact
Toll Free Number+1 (877) 462-2282